MedTech News
.................... by Andrew Celentano
Magnetic screw robot drills through brain tissue and retraces its path in lab tests
Researchers from the UT and Radboudumc have steered a tiny screw-shaped robot through real brain tissue, controlled only by a magnet outside the body. The test used sheep brain tissue in the lab. The team built a model that predicts exactly when such a robot loses control, a step towards treating stroke and tumors deep in the brain without open surgery. The study is published in the journal Advanced Science.
Laser therapy offers weapon against deadly brain tumors
For patients facing a diagnosis of glioblastoma—one of the most aggressive and devastating forms of brain cancer—the standard path forward has long meant invasive open-skull surgery and a daunting prognosis.
DNA shaper steers nervous system development
A study of worms finds a protein that helps shape the structure of the genome is critical for establishing the identity of some neurons.
Lantheus Holdings’ Alzheimer’s radiodiagnostic secures FDA approval
Lantheus’s radiodiagnostic is designed to identify cognitively impaired patients who have tau neurofibrillary tangle (NFT) pathology.
OncoSil obtains FDA humanitarian exemption for bile duct cancer treatment
OncoSil’s device is designed for implantation into solid tumours via injection under endoscopic ultrasound guidance.
Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software
Johnson & Johnson MedTech (NYSE: JNJ) today announced the launch of Monarch Quest 3, the latest software iteration for its Monarch robotically assisted bronchoscopy platform.
Wearable smart patch could automatically deliver aid during a fentanyl overdose
A patch smaller than a penny could one day save the lives of people experiencing a fentanyl overdose—even when no one else is there to help.
New way to help CAR-T cells fight solid tumors could change cancer treatment
For more than a decade, CAR-T cell therapy has been one of the biggest breakthroughs in cancer medicine. By reprogramming a patient’s own immune cells to attack cancer, doctors have produced remarkable results against certain blood cancers, offering hope to patients who once had few treatment options.